Type 2 Diabetes

Excellence Forum

Leaders in the field share expert insights and institutional best practices.

Featured

Poll
Poll
07/17/2024
There are “myths” that surround the use of GLP-1 receptor agonists among patients, and it is a health care provider’s role to help their patients understand the benefits and adverse effects of these...
07/17/2024
Podcast
Podcast
07/15/2024
In this podcast, Diana Isaacs, PharmD, CDCES, talks about continuous glucose monitoring (CGM) technology and how it can be used for medicine adjustments and lifestyle interventions for patients with...
07/15/2024
research summary
research summary
06/18/2024
In a recent retrospective cohort study, researchers examined changes in the medication regimens of patients with type 2 diabetes following the initiation of second-line therapy.
06/18/2024

Interactive Features

Poll
Poll
07/17/2024
There are “myths” that surround the use of GLP-1 receptor agonists among patients, and it is a health care provider’s role to help their patients understand the benefits and adverse effects of these...
07/17/2024
Pediatric Pearl
Person pricking their finger with a glucose monitor
Pediatric Pearl
10/28/2023
Your patient is a 12-year-old girl who is overweight. Obesity runs in her family’s history and her father has type 2 diabetes. Her parents believe she should be screened for diabetes.
10/28/2023
Nutritional Pearl
A person cycling.
Nutritional Pearl
07/10/2023
Your patient is a 55-year-old man with type 2 diabetes who is worried about his health as he ages. He asks you if there are any recommended forms of exercise that can help him feel better about his health....
07/10/2023

Clinical Insights

Podcast
Podcast
07/15/2024
In this podcast, Diana Isaacs, PharmD, CDCES, talks about continuous glucose monitoring (CGM) technology and how it can be used for medicine adjustments and lifestyle interventions for patients with...
07/15/2024
Video
Video
06/17/2024

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC

 

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC  
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about how clinicians can individualize care for their patients with type 2 diabetes, including strategies that can be used, what...
06/17/2024
Video
Video
06/11/2024

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC

Kathryn Kreider, DNP, APRN, FAANP, FNP-BC
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
06/11/2024
Video
Video
03/12/2024

Angela Golden, DNP, FNP-C

Angela Golden, DNP, FNP-C
In this video, Angela Golden, DNP, FNP-C, discusses evidence-based approaches in the management of patients with obesity, including the use of medications, surgery, and controversies. 
03/12/2024
Expert Q&A
Dr Tang
Expert Q&A
02/20/2024
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
02/20/2024